Eli Lilly (LLY-N) said on Wednesday patients on obesity drug Zepbound lost 47 per cent more weight than those who were given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback